National Institutes of Health: Pancytopenia trials

The registry lists 11 Pancytopenia studies with National Institutes of Health as lead sponsor. 0 are open to participants now and 5 have results posted.

Phase 1 5Phase 2 5Phase 3 1No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Eltrombopag for Fanconi AnemiaActive, not recruitingNCT03206086Phase 2Results posted
• Eltrombopag With Standard Immunosuppression for Severe Aplastic AnemiaActive, not recruitingNCT01623167Phase 1/2Results posted
• Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic AnemiaCompletedNCT01193283Phase 1/2Results posted
• A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic AnemiaCompletedNCT01187017Phase 1/2Results posted
• Three Immunosuppressive Treatment Regimens for Severe Aplastic AnemiaCompletedNCT00260689Phase 2Results posted
• Identifying Characteristics of Bone Marrow Failure SyndromesStatus unknownNCT00315419
• Cytokine Gene Polymorphisms in Bone Marrow FailureCompletedNCT00085670
• Gene Therapy for the Treatment of Fanconi's Anemia Type CCompletedNCT00001399Phase 1
• Stem Cell Factor Medication for Aplastic AnemiaCompletedNCT00001398Phase 1
• Collection of Blood From Patients With PancytopeniaCompletedNCT00001214
• Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic DisordersCompletedNCT00000597Phase 3